When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 22 Hits
  • Search Condition : Filter (MeSH = Neovascularization, Pathologic / drug therapy)
Species Resource Title
Human and Animal Cells RBE(RCB1292) , TFK-1(RCB2537) Inhibition of serine/arginine-rich protein kinase-1 (SRPK1) prevents cholangiocarcinoma cells induced angiogenesis.
Human and Animal Cells HSC-2(RCB1945) Efficacy of schedule-dependent metronomic S-1 chemotherapy in human oral squamous cell carcinoma cells.
Human and Animal Cells NUGC-4(RCB1939) The novel VEGF receptor/MET-targeted kinase inhibitor TAS-115 has marked in vivo antitumor properties and a favorable tolerability profile.
Human and Animal Cells HSC-2(RCB1945) , HSC-4(RCB1902) Efficacy of a Novel Oral Chemotherapeutic Agent, TAS-102, Against Human Oral Squamous Cell Carcinoma Cells.
Human and Animal Cells MKN45(RCB1001) Anti-angiogenic and anti-tumor effects of TAK-593, a potent and selective inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinase.
Human and Animal Cells MH7A(RCB1512) Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways.
Human and Animal Cells LLC(RCB0558) , OP9(RCB1124) LPA4-Mediated Vascular Network Formation Increases the Efficacy of Anti-PD-1 Therapy against Brain Tumors.
Human and Animal Cells B901L(RCB3530) MALDI mass spectrometry imaging of erlotinib administered in combination with bevacizumab in xenograft mice bearing B901L, EGFR-mutated NSCLC cells.
Human and Animal Cells Saos-2 Epigenetic modulators hydralazine and sodium valproate act synergistically in VEGI-mediated anti-angiogenesis and VEGF interference in human osteosarcoma and vascular endothelial cells.
Human and Animal Cells LLC(RCB0558) , KLN205(RCB2623) , OP9(RCB1124) Endothelial Side Population Cells Contribute to Tumor Angiogenesis and Antiangiogenic Drug Resistance.
Human and Animal Cells TGBC1TKB(RCB1129) Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models.
Human and Animal Cells TKKK(RCB1907) Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma.
Human and Animal Cells GSU(RCB2278) , Kato III(RCB2088) , KE-97(RCB1435) , MKN45(RCB1001) , NUGC-4(RCB1939) A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activities.
Human and Animal Cells Combination therapy of cilengitide with belotecan against experimental glioblastoma.
Human and Animal Cells Novel HSP90 inhibitor NVP-AUY922 enhances the anti-tumor effect of temsirolimus against oral squamous cell carcinoma.
Human and Animal Cells HuH-28(RCB1943) , TGBC1TKB(RCB1129) Antitumor activity of Src inhibitor saracatinib (AZD-0530) in preclinical models of biliary tract carcinomas.
Human and Animal Cells C2C12(RCB0987) Acetylcholinesterase inhibitors attenuate angiogenesis.
Human and Animal Cells RCN-9(RCB0511) Anti-tumor activity and tumor vessel normalization by the vascular endothelial growth factor receptor tyrosine kinase inhibitor KRN951 in a rat peritoneal disseminated tumor model.
Human and Animal Cells CACO-2(RCB0988) , PMF-ko14(RCB1426) 4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid inhibits angiogenesis in colon cancer through reduced expression of vascular endothelial growth factor.
Human and Animal Cells LM8(RCB1450) Ketoprofen in topical formulation decreases the matrix metalloproteinase-2 expression and pulmonary metastatic incidence in nude mice with osteosarcoma.